Mark Kawakami - 09 May 2025 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role: Chief Financial Officer
Signature: Mark Kawakami, by Attorney-in-fact, Solaeta Chan
Issuer symbol: RKDA
Transactions as of: 09 May 2025
Net transactions value: $0
Form type: 4
Filing time: 12 May 2025, 20:56:01 UTC
Previous filing: 05 Feb 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kawakami Mark	Chief Financial Officer	C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS	Mark Kawakami, by Attorney-in-fact, Solaeta Chan	12 May 2025	0002030709

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RKDA	Stock Option (Right to Buy)	Award	$0	+12,500	+58%	$0.000000	33,987	09 May 2025	Common Stock	12,500	$3.88	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.